As the expression of TRPC1 and STIM1 is enhanced in CRC cells relative to normal colonic cells [22], the present results indicate that DFMO treatment reverses, at least partially, the changes in expression of proteins involved in SOCE associated to CRC. This evidence concerns the gene STIM1 and colorectal carcinoma.